SRT1720, a potent activator of SIRT1, promotes renal fibrosis via increased phosphorylation of epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor β (PDGFRβ). Here, SIRT1 is linked to renal fibrosis.